Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Pharvaris N.V. Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium August 28, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update August 14, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Announces Annual Meeting of Shareholders June 11, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses June 04, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses May 13, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update May 08, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update April 10, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer April 10, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference April 04, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses March 18, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses March 06, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris to Participate in the Leerink Global Biopharma Conference 2024 March 05, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting February 22, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Announces Extraordinary Meeting of Shareholders February 16, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris to Present at the WSAAI Annual Meeting 2024 January 26, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks January 22, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities January 05, 2024 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Presents Deucrictibant Clinical Data and Analysis of Endpoints for Trials of On-demand Treatment of HAE at the GA²LEN UCARE Conference 2023 December 08, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Announces Pricing of $300 Million Underwritten Offering of Ordinary Shares and Pre-funded Warrants December 06, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks December 06, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris to Present at the GA²LEN UCARE Conference 2023 November 30, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer November 15, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting November 09, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update November 02, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris To Present at the ACAAI 2023 Annual Scientific Meeting October 30, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris To Present at the APAAACI 2023 International Conference October 13, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris To Present at the CIIC Fall 2023 Conference October 04, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris To Participate in the 2023 Cantor Global Healthcare Conference September 19, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris To Present at the 18th German Allergy Congress September 06, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference September 06, 2023 From Pharvaris N.V. Via GlobeNewswire Tickers PHVS Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.